THERMAL PULSATION SYSTEM FOR MGD
Alcon introduced the Systane iLux2 meibomian gland dysfunction (MGD) thermal pulsation system. With new imaging technology to capture infrared photos and HD video of the meibomian glands, the device allows patients to see the need for treatment and visualize their procedure, and experience results in as little as one week, the company says. Eye care providers can customize the device’s heat and compression across each treatment zone. The Systane iLux2 MGD thermal pulsation system allows practitioners to tailor MGD treatment to the needs of each of their patients in eight to twelve minutes, Alcon says.
Alcon SystaneiLux.com
TESTS ADDED TO PLATFORM
Heru Inc. announced two new testing modalities on its multi-modal, cloud-based platform: Fast Pattern Suprathreshold Visual Field and the Farnsworth D-15 extended color vision exam. The first performs a screening in 20 seconds without refractive correction, with results available in real-time. The latter eliminates standardized plates or discs, providing an efficient solution for detecting and classifying color vision deficiencies, the company says. The exam is billable to insurance and supported by ICD-10 codes. The wearable device now includes six diagnostic exams.
Heru www.seeheru.com
IMAGING MODULE FOR SLIT LAMPS
The Haag-Streit Imaging Module 910 provides slit lamp images at the push of a button, allowing eye care professionals to concentrate on examining patients. The Imaging Module 910 does not require software. It offers an improved camera sensor, superb optics, and features, such as a performant auto-exposure mode and automatic aperture control, according to Haag-Streit. The module’s image selection algorithm chooses the best image. Additionally, the Imaging Module 910 can be used two different ways. In “standalone” mode, it stores images directly in the EHR system with no extra software needed. In “EyeSuite mode,” image editing and other features are available.
Haag-Streit Haag-Streit.com
NEXT GENERATION SELF-TONOMETER
Icare USA, Inc. announced U.S. Food and Drug Administration 510(k) clearance for the company’s self-tonometer, the iCare HOME2, which measures patients’ IOP outside normal clinic hours. Specifically, the device allows patients to collect IOP measurements while patients are supine, reclined, and sitting. Cloud-based software, iCare CLINIC, stores IOP data measured by the device and provides health care professionals with an overview of changes in patients’ IOP status, the company says. When used with the iCare HOME2, the PATIENT2 mobile app allows patients to share IOP measurements via Bluetooth using their smartphone, for health care professional review.
Icare USA icare-world.com/us/product/icare-home2/
All information provided courtesy of the respective company.
![]({"src":"/media/i4mhu2ar/cover_om_0522.jpg","focalPoint":null,"crops":[{"alias":"thumbnail","width":1110,"height":700,"coordinates":null}]})